Bio-Sourcing is developing a new generation of biotherapeutics, particularly monoclonal antibodies, for global unmet medical needs, making them more available, affordable and sustainable.
BioMilk, Bio-Sourcing's proprietary platform, is changing the design paradigm of these biotherapeutics by mastering several breakthrough technologies, including genome editing (CRISPR), an cloning.
BioSourcing's disruptive approach dramatically reduces capital requirements and production costs, especially at high volumes, and improves the quality/efficiency of biopharmaceuticals through better glycosylation and oral presentation development.
Bio-Sourcing makes an important contribution to sustainable development, especially by drastically reducing the carbon footprint.
Bio-Sourcing is a fully operational biotechnology company based in Liège, Belgium. Its team consists of the best scientists, international experts in their field, and has established strategic partnerships with leading companies in the pharmaceutical and biotechnology industries.